Table 2.
Patients, N | (%) | ||
---|---|---|---|
Sex, Race/Ethnicity | |||
Male | 26 | 68% | |
Female | 12 | 32% | |
NHW | 37 | 97% | |
NHB | 1 | 3% | |
Age (years) | |||
< 45 | 6 | 16% | |
45–60 | 16 | 42% | |
> 60 | 16 | 42% | |
Range | 37 – 79 | ||
Average | 57.5 | ||
Tumor Location | |||
Gingival | 1 | 3% | |
Floor of Mouth | 6 | 16% | |
Mandibular | 2 | 5% | |
Maxillary | 1 | 3% | |
Retromolar | 3 | 8% | |
Tongue | 24 | 65% | |
Tumor Stage | |||
1 | 10 | 27% | |
2 | 9 | 24% | |
3 | 6 | 16% | |
4 | 12 | 32% | |
HPV Status | |||
− | 24 | 83% | |
+ | 5 | 17% | |
Smoking Status | |||
Never | 12 | 32% | |
Former | 9 | 24% | |
Current | 17 | 45% | |
Alcohol Use | |||
Never | 10 | 28% | |
Former | 8 | 22% | |
Current | 18 | 50% | |
BMI | |||
< 18.50 | underweight | 1 | 3% |
18.50 – 24.99 | normal | 8 | 21% |
≥ 25.00 | overweight | 29 | 76% |
≥ 30.00 | obese | 19 | 50% |
Range | 16 – 48 | ||
Average | 29.5 | ||
Duration (Days) | |||
< 7 | 4 | 13% | |
7–21 | 23 | 77% | |
> 21 | 3 | 10% | |
Range | 5 – 34 | ||
Average | 13.9 | ||
Median | 12.5 | ||
Dose (Troches) | |||
< 166 | 18 | 60% | |
166 – 250 | 8 | 27% | |
> 250 | 4 | 13% | |
Range | 60 – 408 | ||
Average | 165.5 | ||
Median | 141.0 |